BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/15/2019 7:45:48 AM | Browse: 756 | Download: 1466
 |
Received |
|
2019-06-04 01:45 |
|
Peer-Review Started |
|
2019-06-06 10:32 |
|
To Make the First Decision |
|
2019-08-28 05:24 |
|
Return for Revision |
|
2019-08-30 03:14 |
|
Revised |
|
2019-09-07 06:37 |
|
Second Decision |
|
2019-09-12 10:28 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-09-13 03:59 |
|
Articles in Press |
|
2019-09-13 03:59 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2019-09-24 10:22 |
|
Typeset the Manuscript |
|
2019-10-23 02:07 |
|
Publish the Manuscript Online |
|
2019-11-15 07:45 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Revisiting oral fluoropyrimidine with cetuximab in metastatic colorectal cancer: Real-world data in Chinese population
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ka-On Lam, Man-Chi Fu, Kin-Sang Lau, Kam-Mo Lam, Cheuk-Wai Choi, Wan-Hang Chiu, Cheng-Man Yuen, Lai-Han Kwok, Fong-Kit Tam, Wing-Lok Chan, Sum-Yin Chan, Pui-Ying Ho, To-Wai Leung and Ho‐Fun Lee |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ka-On Lam, MBBS, Assistant Professor, Clinical Oncology, The University of Hong Kong, 1/F, Professorial Block, Queen Mary Hospital
102 Pokfulam Road, Hong Kong NA, Hong Kong, China. lamkaon@hku.hk |
| Key Words |
Capecitabine; 5-Fluorouracil; Cetuximab; Metastatic colorectal cancer; Chinese; |
| Core Tip |
Cetuximab in combination with oral fluoropyrimidine (FP) remains controversial in metastatic colorectal cancer. A retrospective cohort analysis was performed to compare oral FP with infusional FP in combination with cetuximab in Chinese population in the real-world setting. Our analysis demonstrated comparable efficacy and safety profiles of cetuximab in combination with both oral and infusional FP. Thus, oral FP-based chemotherapy should be considered as a valid option in Chinese patients receiving cetuximab. |
| Publish Date |
2019-11-15 07:45 |
| Citation |
Lam KO, Fu MC, Lau KS, Lam KM, Choi CW, Chiu WH, Yuen CM, Kwok LH, Tam FK, Chan WL, Chan SY, Ho PY, Leung TW, Lee HF. Revisiting oral fluoropyrimidine with cetuximab in metastatic colorectal cancer: Real-world data in Chinese population. World J Gastrointest Oncol 2019; 11(11): 1031-1042 |
| URL |
https://www.wjgnet.com/1948-5204/full/v11/i11/1031.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v11.i11.1031 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
